|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
ADXN
|
Addex Therapeutics Ltd
|
US
|
NASDAQ
|
|
AEMD
|
Aethlon Medical, Inc.
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
DSGN
|
Design Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ENZ
|
Enzo Biochem, Inc.
|
US
|
NYSE
|
|
FLGT
|
Fulgent Genetics, Inc.
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
US
|
NASDAQ
|
|
IKT
|
Inhibikase Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MYO
|
Myomo Inc.
|
US
|
AMEX
|
|
NLSP
|
NLS Pharmaceutics Ltd.
|
US
|
NASDAQ
|
|
NVTA
|
Invitae Corporation
|
US
|
NYSE
|
|
OVID
|
Ovid Therapeutics Inc.
|
US
|
NASDAQ
|
|
PMN
|
ProMIS Neurosciences Inc.
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RLMD
|
Relmada Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VAXX
|
Vaxxinity, Inc.
|
US
|
NASDAQ
|